Brixo
Skip to main content
Back to Healthcare Agents

Founded

2021

Funding

$210M Series B (2025)

OpenEvidence: AI Medical Knowledge Platform for Clinicians

OpenEvidence is an AI-driven medical knowledge platform designed for clinicians to rapidly find, synthesize, and cite peer‑reviewed evidence during patient care. It aggregates top clinical sources (NEJM, JAMA, PubMed, and major guidelines) and delivers natural‑language answers with inline citations and auditable source trails across web and mobile.

  • Website: [OpenEvidence](https://www.openevidence.com/)
  • About the company: [About OpenEvidence](https://www.openevidence.com/about)
  • What OpenEvidence Does

  • Provides a citation‑first agent that answers clinical questions in plain English with clickable references and source passages.
  • Aggregates and ranks evidence across journals, PubMed, and guideline repositories to surface the most relevant literature fast.
  • Maintains an audit trail, lets users drill into abstracts and PDFs, and flags uncertainty when evidence is weak.
  • Core Capabilities

  • Evidence synthesis with inline citations and source inspection
  • Ranked retrieval across NEJM, JAMA Network content, PubMed, and major guidelines
  • Differential diagnosis support, therapy comparisons, and dosing details with references
  • Uncertainty and evidence‑strength signaling to mitigate overconfidence
  • Web, iOS, and Android access for point‑of‑care and on‑the‑go use
  • Download and learn more via [OpenEvidence](https://www.openevidence.com/).

    Sources and Coverage

  • Peer‑reviewed journals and clinical repositories including NEJM, JAMA Network content, PubMed, and major guidelines
  • Emphasis on freshness, speed, and breadth of primary literature compared with traditional point‑of‑care references
  • NEJM and JAMA partnerships:

  • [OpenEvidence + NEJM Group](https://www.openevidence.com/announcements/openevidence-and-nejm)
  • JAMA Network content coverage noted in product materials
  • Platform, Security, and Enterprise

  • Platforms: Web, iOS, and Android (mobile apps highlighted on the site)
  • Enterprise features for health systems:
  • Single Sign‑On (SSO)
  • PHI‑safe use with BAA pathways
  • Workflow integrations via Microsoft collaboration
  • Microsoft collaboration announcement: [Bringing clinical evidence and guidelines into enterprise clinician workflows](https://www.openevidence.com/announcements/openevidence-collaborates-with-microsoft-to-expand-ai-leadership-in-healthcare-bringing-clinical-evidence-and-guidelines-to-enterprise-clinician-workflows)
  • Who It’s For

  • Physicians, residents, PAs, NPs, pharmacists, and clinical librarians
  • Academic medical centers and hospital systems needing enterprise controls and integration
  • Clinicians who want rapid literature synthesis with verifiable source links
  • Common Clinical Use Cases

  • Rapid evidence checks at the bedside with citations
  • Building and comparing differentials
  • Pulling dosing, contraindications, and guideline‑directed therapy with links to the primary source
  • Preparing consult notes with cited evidence passages
  • Teaching, journal club prep, and staying current with high‑impact journals
  • How It Compares

  • Versus search tools (e.g., PubMed): adds ranked retrieval across sources, automatic synthesis, and inline citations.
  • Versus traditional reference products: emphasizes freshness, speed, and breadth of the primary literature.
  • Tradeoffs cited by users: verify claims and watch for occasional hallucinations when evidence is thin.
  • Pricing and Access

  • Free tier for individual clinicians; mobile apps are free to download
  • Enterprise licensing for organizations, with SSO/BAA and integrations
  • Learn more on the [OpenEvidence site](https://www.openevidence.com/)
  • Partnerships, Claims, and Funding

  • NEJM Group and JAMA Network content collaborations: [NEJM partnership](https://www.openevidence.com/announcements/openevidence-and-nejm)
  • Microsoft enterprise collaboration: [Announcement](https://www.openevidence.com/announcements/openevidence-collaborates-with-microsoft-to-expand-ai-leadership-in-healthcare-bringing-clinical-evidence-and-guidelines-to-enterprise-clinician-workflows)
  • Notable claim: first AI to score 100% on the USMLE (press release): [USMLE announcement](https://www.openevidence.com/announcements/openevidence-creates-the-first-ai-in-history-to-score-a-perfect-100percent-on-the-united-states-medical-licensing-examination-usmle)
  • Funding coverage and investor interest:
  • [GV profile](https://www.gv.com/news/openevidence-ai-doctors)
  • [FierceHealthcare coverage](https://www.fiercehealthcare.com/ai-and-machine-learning/openevidence-raises-210m-unveils-ai-agents-built-advanced-medical-research)
  • Clinical Evaluation

  • Peer‑reviewed evaluation of OpenEvidence for clinical questions: [NIH/PMC article](https://pmc.ncbi.nlm.nih.gov/articles/PMC12033599/)
  • User Sentiment Snapshot

    Pros

  • Fast path to relevant papers and guidelines with source links:
  • [r/emergencymedicine](https://www.reddit.com/r/emergencymedicine/comments/1eoafxh/how_reliable_is_openevidencecom/): “gets me to some solid articles around a question very quickly”
  • Useful to kickstart differentials and planning:
  • [r/physicianassistant](https://www.reddit.com/r/physicianassistant/comments/1k2lq47/what_do_you_use_open_evidence_for/): “use it for differentials prior to seeing patients… helped me become more independent”
  • Strong starting point for difficult cases (verify afterward):
  • [r/Psychiatry](https://www.reddit.com/r/Psychiatry/comments/1fulw6k/open_evidence_accuracyusefulness/): “great place to start research or get some ideas… always fact check”
  • Growing awareness/adoption:
  • [r/Residency](https://www.reddit.com/r/Residency/comments/1l10gec/hi_colleagues_i_just_been_wondering_does_anyone/): “All the cool kids seem to use OpenEvidence”
  • Cons

  • Occasional hallucinations; verify claims:
  • [r/Residency](https://www.reddit.com/r/Residency/comments/1lt5nzj/open_evidence/): “Open Evidence is great. Just be careful because it can still hallucinate”
  • Concerns about fabricated or weak references when evidence is thin:
  • [r/hospitalist](https://www.reddit.com/r/hospitalist/comments/1je4ria/open_evidence/): “fabricates evidence with poor references”
  • Some users find answers generic or need more frictionless citations:
  • [r/physicianassistant](https://www.reddit.com/r/physicianassistant/comments/1lz87o4/alternatives_to_openevidence/): “generic answers… citations are always for papers I need to plug back in…”
  • Not a full replacement for point‑of‑care references in some workflows:
  • [r/Residency](https://www.reddit.com/r/Residency/comments/1lt5nzj/open_evidence/): “UpToDate is a better place to go overall”
  • Quick Facts

  • Company: OpenEvidence
  • Category: AI medical knowledge platform with a citation‑first agent
  • Core sources: NEJM, JAMA Network content, PubMed, major guidelines
  • Platforms: Web, iOS, Android
  • Users: Verified clinicians; enterprise deployments via health systems
  • Security: Enterprise path with SSO and BAA for PHI‑safe workflows
  • Free trial: Yes — free tier available; enterprise features require a paid agreement
  • For announcements and product updates, visit the [OpenEvidence Newsroom](https://www.openevidence.com/announcements/).

    Related Companies

    Abridge logo

    Abridge

    Abridge was founded in 2018 with the mission of powering deeper understanding in healthcare. Our Best in KLAS AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients. Our enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time, with deep EMR integrations. Powered by Linked Evidence and our purpose-built, auditable AI, we are the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output. As pioneers in generative AI for healthcare, we are setting the industry standards for the responsible deployment of AI across health systems.

    Ambience Healthcare logo

    Ambience Healthcare

    Ambience Healthcare is the leading AI platform for documentation, coding, and clinical workflows, built to reduce administrative burden and protect revenue integrity at the point of care. Trusted by top health systems across North America, Ambience’s platform is live across outpatient, emergency, and inpatient settings, supporting more than 100 specialties with real-time, coding-aware documentation. The platform integrates directly with Epic, Oracle Cerner, athenahealth, and other major EHRs. Founded in 2020 by Mike Ng and Nikhil Buduma, Ambience is headquartered in San Francisco and backed by Oak HC/FT, Andreessen Horowitz (a16z), OpenAI Startup Fund, Kleiner Perkins, and other leading investors. For official information or questions on available roles, please visit https://careers.ambiencehealthcare.com

    Corti logo

    Corti

    Corti offers the worlds most powerful AI models for healthcare, directly available through our API.

    Hippocratic AI logo

    Hippocratic AI

    Nabla logo

    Nabla

    Nabla is on a mission to restore the human connection at the heart of healthcare through industry-leading clinical AI that optimizes clinical and financial workflows. Our AI assistant helps clinicians generate high-quality notes in seconds and streamline multiple workflows through ambient documentation, dictation, and real-time coding support. Nabla integrates with all major EHRs, supports more than 35 languages, and is used across over 130 health systems and provider groups. Nabla is building the most advanced agentic AI assistant for clinicians, evolving into an Adaptive Agentic Platform: a smarter assistant that helps with coding, proactive EHR actions, and can support across new care settings and clinical roles. Nabla was founded by Alex LeBrun (CEO), Delphine Groll (COO), and Martin Raison (CTO). Its leadership includes Dr. Ed Lee, Chief Medical Officer and former CIO of The Permanente Federation. Nabla’s advisors include Yann LeCun (Meta) and Tony Fadell (Build Collective). The company has raised $120 million from HV Capital, Highland Europe, Cathay Innovation, and others.